The role of interleukin 17 in Crohn's disease-associated intestinal fibrosis

Fibrogenesis and Tissue Repair

Volumn 6, Issue 1, 2013, Pages

  Biancheri, P ^a,b   Pender, Sylvia L F ^c   Ammoscato, Francesca ^a   Giuffrida, Paolo ^b   Sampietro, Gianluca ^d   Ardizzone, Sandro ^d   Ghanbari, Amir ^a   Curciarello, Renata ^a   Pasini, Alessandra ^b   Monteleone, Giovanni ^e   Corazza, Gino R ^b   MacDonald, Thomas T ^a   Di Sabatino, Antonio ^b  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF PAVIA   (Italy)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^d UNIVERSITY OF MILAN   (Italy)

^e UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Collagen; Interleukin 25; Myofibroblast; Stricture; TIMP 1

Indexed keywords

COLLAGEN; INTERLEUKIN 17; INTERLEUKIN 17 RECEPTOR; INTERLEUKIN 25; INTERLEUKIN 25 RECEPTOR; INTERLEUKIN 6; INTERLEUKIN RECEPTOR; MACROPHAGE ELASTASE; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELL MIGRATION; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; CYTOKINE PRODUCTION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; INTESTINAL FIBROSIS; MYOFIBROBLAST; PROTEIN EXPRESSION; PROTEIN FUNCTION; UPREGULATION;

EID: 84879806308     PISSN: None     EISSN: 17551536     Source Type: Journal    
DOI: 10.1186/1755-1536-6-13     Document Type: Article

References (38)

1. Wynn TA, Ramalingam TR: Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nat Med 2012, 18:1028-1040.
2. Gabbiani G: The myofibroblast in wound healing and fibrocontractive diseases. J Pathol 2003, 200:500-503.
3. Wynn TA: Fibrotic disease and the T(H)1/T(H)2 paradigm. Nat Rev Immunol 2004, 4:583-594.
4. Gaffen SL: Recent advances in the IL-17 cytokine family. Curr Opin Immunol 2011, 23:613-619.
5. Valente AJ, Yoshida T, Gardner JD, Somanna N, Delafontaine P, Chandrasekar B: Interleukin-17A stimulates cardiac fibroblast proliferation and migration via negative regulation of the dual-specificity phosphatase MKP-1/DUSP-1. Cell Signal 2012, 24:560-568.
6. Meng F, Wang K, Aoyama T, Grivennikov SI, Paik Y, Scholten D, Cong M, Iwaisako K, Liu X, Zhang M, Osterreicher CH, Stickel F, Ley K, Brenner DA, Kisseleva T: Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice. Gastroenterology 2012, 143:765-776.
7. Okamoto Y, Hasegawa M, Matsushita T, Hamaguchi Y, Huu DL, Iwakura Y, Fujimoto M, Takehara K: Potential roles of interleukin-17A in the development of skin fibrosis in mice. Arthritis Rheum 2012, 64:3726-3735.
8. Mi S, Li Z, Yang HZ, Liu H, Wang JP, Ma YG, Wang XX, Liu HZ, Sun W, Hu ZW: Blocking IL-17A promotes the resolution of pulmonary inflammation and fibrosis via TGF-beta1-dependent and -independent mechanisms. J Immunol 2011, 187:3003-3014.
9. Létuvé S, Lajoie-Kadoch S, Audusseau S, Rothenberg ME, Fiset PO, Ludwig MS, Hamid Q: IL-17E upregulates the expression of proinflammatory cytokines in lung fibroblasts. J Allergy Clin Immunol 2006, 117:590-596.
10. Gregory LG, Jones CP, Walker SA, Sawant D, Gowers KH, Campbell GA, McKenzie AN, Lloyd CM: IL-25 drives remodelling in allergic airways disease induced by house dust mite. Thorax 2013, 68:82-90.
11. Rovedatti L, Kudo T, Biancheri P, Sarra M, Knowles CH, Rampton DS, Corazza GR, Monteleone G, Di Sabatino A, Macdonald TT: Differential regulation of interleukin 17 and interferon gamma production in inflammatory bowel disease. Gut 2009, 58:1629-1636.
12. Caruso R, Sarra M, Stolfi C, Rizzo A, Fina D, Fantini MC, Pallone F, MacDonald TT, Monteleone G: Interleukin-25 inhibits interleukin-12 production and Th1 cell-driven inflammation in the gut. Gastroenterology 2009, 136:2270-2279.
13. Burke JP, Mulsow JJ, O'Keane C, Docherty NG, Watson RW, O'Connell PR: Fibrogenesis in Crohn's disease. Am J Gastroenterol 2007, 102:439-448.
14. Regan MC, Flavin BM, Fitzpatrick JM, O'Connell PR: Stricture formation in Crohn's disease: the role of intestinal fibroblasts. Ann Surg 2000, 231:46-50.
15. Andoh A, Bamba S, Brittan M, Fujiyama Y, Wright NA: Role of intestinal subepithelial myofibroblasts in inflammation and regenerative response in the gut. Pharmacol Ther 2007, 114:94-106.
16. Di Sabatino A, Jackson CL, Pickard KM, Buckley M, Rovedatti L, Leakey NA, Picariello L, Cazzola P, Monteleone G, Tonelli F, Corazza GR, MacDonald TT, Pender SL: Transforming growth factor beta signalling and matrix metalloproteinases in the mucosa overlying Crohn's disease strictures. Gut 2009, 58:777-789.
17. Okuno T, Andoh A, Bamba S, Araki Y, Fujiyama Y, Fujiyama M, Bamba T: Interleukin-1beta and tumor necrosis factor-alpha induce chemokine and matrix metalloproteinase gene expression in human colonic subepithelial myofibroblasts. Scand J Gastroenterol 2002, 37:317-324.
18. Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM, Weaver CT: Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005, 6:1123-1132.
19. Annunziato F, Cosmi L, Santarlasci V, Maggi L, Liotta F, Mazzinghi B, Parente E, Filì L, Ferri S, Frosali F, Giudici F, Romagnani P, Parronchi P, Tonelli F, Maggi E, Romagnani S: Phenotypic and functional features of human Th17. J Exp Med 2007, 204:1849-1861.
20. Steinman L: A brief history of T(H)17, the first major revision in the T(H)1/T(H) 2 hypothesis of T cell-mediated tissue damage. Nat Med 2007, 13:139-145.
21. Monteleone I, Sarra M, Del Vecchio BG, Paoluzi OA, Franzè E, Fina D, Fabrizi A, MacDonald TT, Pallone F, Monteleone G: Characterization of IL-17A-producing cells in celiac disease mucosa. J Immunol 2010, 184:2211-2218.
22. Kobayashi T, Okamoto S, Hisamatsu T, Kamada N, Chinen H, Saito R, Kitazume MT, Nakazawa A, Sugita A, Koganei K, Isobe K, Hibi T: IL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn's disease. Gut 2008, 57:1682-1689.
23. Sarra M, Pallone F, MacDonald TT, Monteleone G: IL-23/IL-17 axis in IBD. Inflamm Bowel Dis 2010, 16:1808-1813.
24. Wilson MS, Madala SK, Ramalingam TR, Gochuico BR, Rosas IO, Cheever AW, Wynn TA: Bleomycin and IL-1beta-mediated pulmonary fibrosis is IL-17A dependent. J Exp Med 2010, 207:535-552.
25. Guan Q, Ma Y, Hillman CL, Qing G, Ma AG, Weiss CR, Zhou G, Bai A, Warrington RJ, Bernstein CN, Peng Z: Targeting IL-12/IL-23 by employing a p40 peptide-based vaccine ameliorates TNBS-induced acute and chronic murine colitis. Mol Med 2011, 17:646-656.
26. Zorzi F, Monteleone I, Sarra M, Calabrese E, Marafini I, Cretella M, Sedda S, Biancone L, Pallone F, Monteleone G: Distinct profiles of effector cytokines mark the different phases of Crohn's disease. PLoS One 2013, 8:e54562.
27. Bamba S, Andoh A, Yasui H, Araki Y, Bamba T, Fujiyama Y: Matrix metalloproteinase-3 secretion from human colonic subepithelial myofibroblasts: role of interleukin-17. J Gastroenterol 2003, 38:548-554.
28. Lawrance IC, Wu F, Leite AZ, Willis J, West GA, Fiocchi C, Chakravarti S: A murine model of chronic inflammation-induced intestinal fibrosis downregulated by antisense NF-kappa B. Gastroenterology 2003, 125:1750-1761
29. Gunther U, Schuppan D, Bauer M, Matthes H, Stallmach A, Schmitt-Gräff A, Riecken EO, Herbst H: Fibrogenesis and fibrolysis in collagenous colitis. Patterns of procollagen types I and IV, matrix-metalloproteinase-1 and -13, and TIMP-1 gene expression. Am J Pathol 1999, 155:493-503.
30. Sharkhuu T, Matthaei KI, Forbes E, Mahalingam S, Hogan SP, Hansbro PM, Foster PS: Mechanism of interleukin-25 (IL-17E)-induced pulmonary inflammation and airways hyper-reactivity. Clin Exp Allergy 2006, 36:1575-1583.
31. Monteleone G, Pallone F, Macdonald TT: Interleukin-25: a two-edged sword in the control of immune-inflammatory responses. Cytokine Growth Factor Rev 2010, 21:471-475.
32. Fichtner-Feigl S, Strober W, Geissler EK, Schlitt HJ: Cytokines mediating the induction of chronic colitis and colitis-associated fibrosis. Mucosal Immunol 2008, 1(Suppl.1):S24-S27.
33. Hueber W, Sands BE, Lewitzky S, Vandemeulebroecke M, Reinisch W, Higgins PD, Wehkamp J, Feagan BG, Yao MD, Karczewski M, Karczewski J, Pezous N, Bek S, Bruin G, Mellgard B, Berger C, Londei M, Bertolino AP, Tougas G, Travis SP: Secukinumab in Crohn's Disease Study Group: Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial. Gut 2012, 61:1693-1700.
34. Best WR, Becktel JM, Singleton JW, Kern F Jr: Development of a Crohn's disease activity index: National Cooperative Crohn's disease study. Gastroenterology 1976, 70:439-444.
35. Maglinte DD, Kelvin FM, Sandrasegaran K, Nakeeb A, Romano S, Lappas JC, Howard TJ: Radiology of small bowel obstruction: contemporary approach and controversies. Abdom Imaging 2005, 30:160-178.
36. Di Sabatino A, Pender SLF, Jackson CL, Prothero JD, Gordon JN, Picariello L, Rovedatti L, Docena G, Monteleone G, Rampton DS, Tonelli F, Corazza GR, MacDonald TT: Functional modulation of Crohn's disease myofibroblasts by anti-TNF antibodies. Gastroenterology 2007, 133:137-149.
37. Pender SL, Tickle SP, Docherty AJ, Howie D, Wathen NC, MacDonald TT: A major role for matrix metalloproteinases in T cell injury in the gut. J Immunol 1997, 158:1582-1590.
38. Rodriguez LG, Wu X, Guan JL: Wound-healing assay. Methods Mol Biol 2005, 294:23-29.